Committee for Orphan Medicinal Products (COMP): 16-18 January 2024

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

• Date:
  Tuesday, 16 January 2024, All day
  Thursday, 18 January 2024, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the COMP meeting 16-18 January 2024

DraftReference Number: EMA/COMP/568809/2023

Minutes of the COMP meeting 16-18 January 2024

AdoptedReference Number: EMA/COMP/47120/2024